Skip to main content
James Casella, MD, Pediatric Hematology & Oncology, Baltimore, MD

JamesFCasellaMD

Pediatric Hematology & Oncology • Baltimore, MD

Professor of Pediatrics, Professor of Oncology, Johns Hopkins University School of Medicine; Chief of Pediatric Hematology

Join to view full profile

Dr. Casella is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Casella's full profile

Already have an account?

  • Office

    200 North Wolfe Street
    Rubenstein BLDG Lower Level
    Baltimore, MD 21287
    Phone+1 443-997-5437
    Fax+1 410-367-2748

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1979 - 1983
  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1979 - 1980
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pediatrics, 1976 - 1979
  • SUNY Upstate Medical University
    SUNY Upstate Medical UniversityClass of 1976

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1980 - 2026
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Proteomic Discovery: Elevated Neurogranin Levels in Children with Sickle Cell Disease
    James F. Casella, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Neurodevelopmental Disorders in Pediatric Sickle Cell Disease
    James F. Casella, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • New Drugs Regrows Hair in 40% of Patients
    New Drugs Regrows Hair in 40% of PatientsMay 26th, 2022
  • Poloxamer 188 Disappoints for Painful SCD Vaso-Occlusive Episodes, Study Showsteaser
    Poloxamer 188 Disappoints for Painful SCD Vaso-Occlusive Episodes, Study ShowsteaserMay 27th, 2021
  • Poloxamer 188 Disappoints for Painful SCD Vaso-Occlusive Episodes, Study Showsteaser
    Poloxamer 188 Disappoints for Painful SCD Vaso-Occlusive Episodes, Study ShowsteaserMay 27th, 2021
  • Join now to see all

Grant Support

  • Clinical Hematology Research Career Development Program (K12) At HopkinsNational Heart, Lung, And Blood Institute2012
  • Hydroxyurea To Prevent CNS Complications Of Sickle Cell Disease In ChildrenNational Heart, Lung, And Blood Institute2011
  • Comprehensive Sickle Cell Center At Jhu And UABNational Heart, Lung, And Blood Institute2009–2011
  • Sickle Cell Scholar ComponentNational Heart, Lung, And Blood Institute2008–2011
  • Longitudinal SIT Trial Plasma Proteomic Biomarker Discovery And Validation In SCINational Heart, Lung, And Blood Institute2008–2011
  • Administrative CoreNational Heart, Lung, And Blood Institute2008–2011
  • Clinical Hematology Research Development Program (K12) At Johns HopkinsNational Heart, Lung, And Blood Institute2006–2010
  • Basic And Translational Research ProgramNational Heart, Lung, And Blood Institute2008
  • Silent Cerebral Infarct Multi-Center Clinical TrialNational Center For Research Resources2006–2007
  • Baby HUGNational Center For Research Resources2005–2007
  • Stroke Prevention Trial In Sickle Cell Anemia (Stop Ii)National Center For Research Resources2004–2005
  • Cognitive And Neuroimaging Studies Of Children With Sickle Cell DiseaseNational Center For Research Resources2004
  • Cognitive And Neuroimaging In Studies Of Children WithNational Center For Research Resources2004
  • Flocor In Patients With Sickle Cell Disease CrisisNational Center For Research Resources2000–2002
  • Phase III Multicntr,Db,Placebo Cont Study Of CRL 5861 In Sickle Cell AnemiaNational Center For Research Resources1999–2002
  • Pediatric Hydroxyuera Phase III Clinical TrialDivision Of Blood Diseases And Resources2000
  • Molecular Analysis Of A Muscle Actin-Capping ProteinNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1992–1996
  • Actin-Capping Protein Interactions In MuscleNational Heart, Lung, And Blood Institute1987–1991
  • Actin Capping Proteins In Platelets And MuscleNational Heart, Lung, And Blood Institute1985–1988

External Links

Dr. James Casella, Dr. James Casella, MD, Dr. J Casella, Dr. James F Casella